Improved Alzheimer's Risk Assessment Tool Developed for Nonwhite Patients

Source Summary

Researchers have developed a more accurate risk assessment method for late-onset Alzheimer's disease among nonwhite patients. Late-onset Alzheimer's is a progressive disorder affecting an estimated 6.9 million people in the U.S., characterized by cognitive decline and memory impairment that typically unfolds over many years. Genetic factors play a central role in determining both the onset and trajectory of cognitive deterioration, with rates of decline varying among individuals.